Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8182)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 12, 2015 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Virology
ISSN
2220-3249
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rowan PJ. What psychiatric screening and monitoring might be needed with the new generation of hepatitis C treatments? World J Virology 2015; 4(1): 13-16 [PMID: 25674513 DOI: 10.5501/wjv.v4.i1.13] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v4/i1/13.htm |
| Number | Citing Articles |
| 1 |
Marta Miarons, Azhara Sánchez-Ulayar, Glòria Sempere, Sergio Marín, Josep Maria Castellví. New direct-acting antivirals for hepatitis C treatment and neuropsychiatric symptoms in psychiatric risk groups. European Journal of Hospital Pharmacy 2019; 26(3): 135 doi: 10.1136/ejhpharm-2017-001352
|
| 2 |
Isak Sundberg, Anders Lannergård, Mia Ramklint, Janet L. Cunningham. Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study. BMC Psychiatry 2018; 18(1) doi: 10.1186/s12888-018-1735-6
|
| 3 |
Ghaydaa A. Shehata, Gellan K. Ahmed, Elham Ahmed Hassan, Abeer Sharaf El-Din Abdel Rehim, Saad Zaky Mahmoud, Noha Ali Masoud, Gehan S. Seifeldein, Waleed Attia Hassan, Khaled O. Aboshaera. Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 2022; 58(1) doi: 10.1186/s41983-022-00568-5
|